Open access
246
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Requirements for Brazilian Outpatient Centers of Excellence in Hidradenitis Suppurativa: Consensus Co-Creative Study
Ericles Andrei Bellei1 Department of Data, Digital, and Innovation, Novartis, São Paulo, BrazilCorrespondence[email protected]
https://orcid.org/0000-0002-6020-6356View further author information
Miriam Emi Makinodan Shirozaki1 Department of Data, Digital, and Innovation, Novartis, São Paulo, BrazilView further author information
, Ana Lia Pradella Puglia2 Immunology Franchise, Novartis, São Paulo, Brazil;3 Department of Scientific Operations, Novartis, São Paulo, Brazil
https://orcid.org/0000-0002-6410-7152View further author information
André Vicente Esteves de Carvalho4 Dermatology, Hospital Moinhos de Ventos de Porto Alegre, Porto Alegre, BrazilView further author information
, Barbara Riquena2 Immunology Franchise, Novartis, São Paulo, Brazil;5 Department of Medical Affairs, Novartis, São Paulo, BrazilView further author information
, Camilla Carlini Vallilo2 Immunology Franchise, Novartis, São Paulo, Brazil;3 Department of Scientific Operations, Novartis, São Paulo, BrazilView further author information
, Danilo de Barros6 Dermatology Service, Hospital Irmandade Santa Casa de Curitiba, Curitiba, BrazilView further author information
, Erika Yumi Tamashiro2 Immunology Franchise, Novartis, São Paulo, BrazilView further author information
, Gabriela Cintra2 Immunology Franchise, Novartis, São Paulo, BrazilView further author information
, Gleison Vieira Duarte7 Dermatology, Instituto Bahiano de Imunoterapia (IBIS), Salvador, Brazil
https://orcid.org/0000-0003-4160-5447View further author information
Maria Cecília da Matta Rivitti-Machado8 Hospital das Clínicas da Faculdade de Medicina, University of São Paulo (USP), São Paulo, Brazil
https://orcid.org/0000-0003-2910-7330View further author information
Renata Ferreira Magalhães9 School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, BrazilView further author information
, Ricardo Figueiredo do Nascimento2 Immunology Franchise, Novartis, São Paulo, BrazilView further author information
, Roberto Tunala5 Department of Medical Affairs, Novartis, São Paulo, BrazilView further author information
, Roberto da Silva10 Department of Dermatology, Rio de Janeiro State University (UERJ), Rio de Janeiro, BrazilView further author information
, Wagner Guimarães Galvão Cesar11 Dermatology, Hospital Alemão Oswaldo Cruz, São Paulo, BrazilView further author information
& Felipe Garutti Thies2 Immunology Franchise, Novartis, São Paulo, BrazilView further author information
show all
Pages 2029-2044
|
Received 25 May 2023, Accepted 30 Jun 2023, Published online: 04 Aug 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.